Alignment Healthcare, Inc. (NASDAQ:ALHC) Insider Andreas P. Wagner Sells 14,878 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Andreas P. Wagner sold 14,878 shares of the firm’s stock in a transaction dated Wednesday, February 12th. The stock was sold at an average price of $14.38, for a total value of $213,945.64. Following the transaction, the insider now directly owns 200,885 shares in the company, valued at approximately $2,888,726.30. The trade was a 6.90 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

Alignment Healthcare Stock Up 1.0 %

ALHC stock opened at $14.52 on Thursday. The stock has a market capitalization of $2.78 billion, a PE ratio of -18.86 and a beta of 1.50. The company has a fifty day moving average of $12.88 and a 200-day moving average of $11.54. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60. Alignment Healthcare, Inc. has a one year low of $4.46 and a one year high of $15.82.

Analysts Set New Price Targets

ALHC has been the topic of a number of research reports. UBS Group raised their price target on Alignment Healthcare from $9.00 to $12.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 30th. Stephens restated an “overweight” rating and set a $17.00 target price on shares of Alignment Healthcare in a research report on Thursday, January 2nd. Barclays upped their price target on shares of Alignment Healthcare from $7.00 to $8.00 and gave the company an “underweight” rating in a research report on Wednesday, October 30th. Finally, Stifel Nicolaus increased their price target on shares of Alignment Healthcare from $14.00 to $16.00 and gave the stock a “buy” rating in a research note on Tuesday, January 14th. One analyst has rated the stock with a sell rating, two have issued a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Alignment Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $11.88.

Institutional Investors Weigh In On Alignment Healthcare

A number of hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its position in Alignment Healthcare by 1.7% during the 4th quarter. Vanguard Group Inc. now owns 9,818,071 shares of the company’s stock worth $110,453,000 after purchasing an additional 166,837 shares during the period. Wellington Management Group LLP grew its holdings in Alignment Healthcare by 77.9% during the fourth quarter. Wellington Management Group LLP now owns 7,438,500 shares of the company’s stock worth $83,683,000 after acquiring an additional 3,257,630 shares during the period. William Blair Investment Management LLC raised its position in Alignment Healthcare by 50.7% in the fourth quarter. William Blair Investment Management LLC now owns 2,972,647 shares of the company’s stock worth $33,442,000 after acquiring an additional 999,940 shares in the last quarter. Geode Capital Management LLC raised its position in Alignment Healthcare by 1.4% in the third quarter. Geode Capital Management LLC now owns 2,442,447 shares of the company’s stock worth $28,875,000 after acquiring an additional 32,839 shares in the last quarter. Finally, State Street Corp lifted its holdings in Alignment Healthcare by 0.9% in the third quarter. State Street Corp now owns 2,252,287 shares of the company’s stock valued at $26,622,000 after acquiring an additional 20,731 shares during the period. Institutional investors and hedge funds own 86.19% of the company’s stock.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.